APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results
Conference Call/Webcast Scheduled for Today at 4:30 PM ET – STONY BROOK, NY / ACCESSWIRE / December 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for its fourth quarter ended September 30, 2023. “Our fiscal fourth quarter concludes a productive [...]